OTC : CHMP

Champion Industries Inc

$0.02 USD

$0 (0.0%)

Volume
51
Average Volume
44
Market Capitalization
$1.13K
P/E Ratio
0.00
Dividend Yield
0.00%
Price Target
Year High
$0.02
Year Low
$0.00
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.76
Company Overview

OTC

Adam Reynolds

Specialty Business Services

Industrials

CHMP

316

US

USD

304-528-2700

158520205

0000019149

Liquidity Metrics

3.06

0.76

0.56

0.02

0.00

Sales & Valuation

$62.23M

0.00

0.00

1.58

0.01

Profitability

-$23.03

-$1.29M

-2.07%

-2.07%

-49.45%

-5.89%

P/E Metrics

0.00

0.00

0.00

Analyst Price Target & Rating

N/A

0/5

0 Analysts

%

Financial Health Scores

0.28

5/9

-$4.44M

$21.84M

$18.65M

-$633.58K

Key Metrics (TTM)

$9.47M

0.15

9.77

0.76

-49.45%

-5.17%

-116961.55%

63.24%

38 days

Company Executives
Name Title
Gregory D. Adkins Controller
Adam Reynolds Chief Executive Officer & President
Donna R. Connelly Secretary
Poll Results

No votes yet today — be the first to share your view!

About Champion Industries Inc (OTC:CHMP) Stock

Champion Industries, Inc., together with its subsidiaries, engages in the production, printing, and sale of printed materials in the United States. The company offers printed materials, including brochures, pamphlets, reports, tags, continuous, and other forms. It also provides office products and office furniture, as well as interior design services. The company was incorporated in 1992 and is headquartered in Huntington, West Virginia. ...

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata

2026-06-29 04:00:00

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQÂ) for the Treatment of Adults and Adolescents with Severe Alopecia Areata

Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis

2026-06-26 08:00:00

Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positi

Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy

2026-06-26 08:00:00

Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) acro

Frequently Asked Questions

What is the current Champion Industries Inc (CHMP) stock price?

Champion Industries Inc(OTC:CHMP) stock price is $0.02 in the last trading session. During the trading session, CHMP stock reached the peak price of $0.02 while $0.0001 was the lowest point it dropped to. The percentage change in CHMP stock occurred in the recent session was 0.0% while the dollar amount for the price change in CHMP stock was $0.

CHMP's industry and sector of operation?

The OTC listed CHMP is part of Specialty Business Services industry that operates in the broader Industrials sector.

Who are the executives of CHMP?

Gregory D. Adkins | Controller
Adam Reynolds | Chief Executive Officer & President
Donna R. Connelly | Secretary
|
|

How many employees does CHMP have?

Number of CHMP employees currently stands at 316. CHMP operates from 2450-90 First Avenue, Huntington, WV 25728, US.

Link for CHMP official website?

Official Website of CHMP is: https://www.champion-industries.com

How do I contact CHMP?

CHMP could be contacted at phone #304-528-2700 and can also be accessed through its website. CHMP operates from 2450-90 First Avenue, Huntington, WV 25728, US.

How many shares of CHMP are traded daily?

The average number of CHMP shares traded daily for last 3 months was 44.

What is the market cap of CHMP currently?

The market value of CHMP currently stands at $1.13K with its latest stock price at $0.02